GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM9043
Query DataSets for GSM9043
Status
Public on Feb 29, 2004
Title
hc4
Sample type
RNA
Source name
adipose tissue
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA was extracted from umbilical subcutaneous adipose tissue from an individual affected with FCHL and exhibiting the USF1 susceptibility haplotype
Submission date
Aug 13, 2003
Last update date
May 28, 2005
Contact name
Massimiliano Gentile
E-mail(s)
[email protected]
Phone
+358-9-47448726
URL
http://www.bioinfo.helsinki.fi
Organization name
Biomedicum Helsinki
Department
Biomedicum Bioinformatics Unit
Lab
Biomedicum Bioinformatics Unit
Street address
Haartmaninkatu 8
City
Helsinki
ZIP/Postal code
000 14
Country
Finland
Platform ID
GPL96
Series (1)
GSE590
USF1 haplotype comparison
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
quality flag: absent, marginal or present
DETECTION P-VALUE
p-value on flag
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
98.4
P
0.012547
AFFX-BioB-M_at
182.9
P
0.000195
AFFX-BioB-3_at
92.5
P
0.00034
AFFX-BioC-5_at
266.6
P
0.000258
AFFX-BioC-3_at
187
P
0.000127
AFFX-BioDn-5_at
217.3
P
0.00007
AFFX-BioDn-3_at
1475.7
P
0.000147
AFFX-CreX-5_at
2465
P
0.000044
AFFX-CreX-3_at
3861.5
P
0.000044
AFFX-DapX-5_at
4.7
A
0.205732
AFFX-DapX-M_at
6.9
A
0.440646
AFFX-DapX-3_at
2
A
0.883887
AFFX-LysX-5_at
4.9
A
0.39692
AFFX-LysX-M_at
1.8
A
0.794268
AFFX-LysX-3_at
1.3
A
0.51489
AFFX-PheX-5_at
0.6
A
0.953518
AFFX-PheX-M_at
0.7
A
0.960339
AFFX-PheX-3_at
2.6
A
0.916408
AFFX-ThrX-5_at
2.4
A
0.794268
AFFX-ThrX-M_at
4.6
A
0.760937
Total number of rows:
22283
Table truncated, full table size
579 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|